{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T14:45:20Z","timestamp":1784126720551,"version":"3.55.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002386","name":"Cairo University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002386","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Solid pseudopapillary neoplasms (SPNs) of the pancreas are rare, low-grade malignancies that predominantly affect young females. Their diagnosis is often facilitated by a characteristic histomorphological pattern and immunohistochemical profile. However, diagnostic challenges persist, especially in pediatric and atypical presentations. Recent attention has focused on the diagnostic value of CD99 and LEF1 in distinguishing SPNs from other pancreatic neoplasms.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>To evaluate the diagnostic accuracy and utility of CD99 and LEF1 as immunohistochemical markers for SPNs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A retrospective analysis of 60 SPN cases diagnosed between 2015 and 2024 was performed. Histopathological features were systematically reviewed, and immunohistochemical staining for CD99, LEF1, \u03b2-catenin, Cyclin D1, PR, Ki-67 was evaluated. Immunohistochemical marker interpretation was standardized using internally validated thresholds informed by existing literature: CD99 was considered positive with\u2009\u2265\u200910% cytoplasmic staining exhibiting paranuclear accentuation; \u03b2-catenin positivity was defined by\u2009\u2265\u20095% nuclear localization; Cyclin D1 by\u2009\u2265\u200910% moderate-to-strong nuclear staining; and progesterone receptor (PR) expression by\u2009\u2265\u20091% nuclear positivity, consistent with hormone receptor evaluation guidelines.<\/jats:p>\n            <jats:p>Marker expression was statistically analyzed for their associations.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>SPNs exhibited a strong female predilection (F:M ratio \u2248 7:1), with a mean age of 32.5\u00a0years. Pediatric cases (<jats:italic>n<\/jats:italic>\u2009=\u20094) displayed higher mean expression of CD99 (73.8%) and LEF1 (86.5%) compared to adults. CD99 showed cytoplasmic positivity with paranuclear accentuation in 96.7% of cases, while LEF1 demonstrated nuclear staining in 91.7%. \u03b2-catenin nuclear localization was observed in 95% of tumors, reflecting Wnt\/\u03b2-catenin pathway activation. Cyclin D1 and PR were expressed in 90% and 88.3% of cases, respectively. Co-expression of \u03b2-catenin, CD99, LEF1, Cyclin D1, and PR was observed in 73.3% of tumors. CD99 and LEF1 inversely correlated with tumor size and proliferative activity (Ki-67), whereas Cyclin D1 and Ki-67 positively correlated with tumor size and lymphovascular invasion (LVI). Pediatric tumors generally exhibited favorable profiles, with limited evidence of LVI.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>SPNs present with distinctive immunohistochemical signatures that are critical for accurate diagnosis, particularly in morphologically ambiguous or pediatric cases. CD99 and LEF1 are highly sensitive markers that, in combination with \u03b2-catenin and Cyclin D1, enhance diagnostic precision. These findings emphasize the central role of Wnt\/\u03b2-catenin signaling in SPN pathogenesis and underscore the importance of integrating clinicopathological and molecular data for comprehensive tumor assessment.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13000-025-01648-9","type":"journal-article","created":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T10:38:33Z","timestamp":1746009513000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Diagnostic insights into solid pseudopapillary neoplasms of the pancreas: a decade of experience with pediatric representation"],"prefix":"10.1186","volume":"20","author":[{"given":"Noura A. A.","family":"Ebrahim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moamen O.","family":"Othman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasha A.","family":"Salama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalia","family":"Abdelfatah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neveen S.","family":"Tahoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,30]]},"reference":[{"key":"1648_CR1","volume-title":"Tumors of the pancreas","author":"VK Frantz","year":"1959","unstructured":"Frantz VK. Tumors of the pancreas. Washington: Armed Forces Institute of Pathology; 1959."},{"key":"1648_CR2","unstructured":"Bosman FT, et al. Tumors of the pancreas. In: WHO Classification of Tumours of the Digestive System. IARC Press; 2019."},{"issue":"5","key":"1648_CR3","first-page":"461","volume":"36","author":"G Kl\u00f6ppel","year":"2000","unstructured":"Kl\u00f6ppel G, et al. Solid pseudopapillary tumors of the pancreas. Histopathology. 2000;36(5):461\u20139.","journal-title":"Histopathology"},{"issue":"7","key":"1648_CR4","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.5858\/2009-0150-CR.1","volume":"134","author":"K Hirano","year":"2010","unstructured":"Hirano K, et al. CD99: A marker for solid pseudopapillary tumor of the pancreas. Arch Pathol Lab Med. 2010;134(7):1060\u20133.","journal-title":"Arch Pathol Lab Med"},{"issue":"12","key":"1648_CR5","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1097\/00000478-200012000-00010","volume":"24","author":"AL Folpe","year":"2000","unstructured":"Folpe AL, Hill CE, Parham DM, O\u2019Shea PA, Weiss SW. Immunohistochemical detection of FLI-1 protein expression: a study of 132 round cell tumors with emphasis on CD99-positive mimics of Ewing\u2019s sarcoma\/primitive neuroectodermal tumor. Am J Surg Pathol. 2000;24(12):1657\u201362. https:\/\/doi.org\/10.1097\/00000478-200012000-00010.","journal-title":"Am J Surg Pathol."},{"issue":"7","key":"1648_CR6","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1097\/PAS.0000000000000846","volume":"41","author":"CR Antonescu","year":"2017","unstructured":"Antonescu CR, Owosho AA, Zhang L, Chen S, Deniz K, Huryn JM, Kao YC, Huang SC, Singer S, Tap W, Schaefer IM, Fletcher CD. Sarcomas With CIC-rearrangements are a distinct pathologic entity with aggressive outcome: a clinicopathologic and molecular study of 115 cases. Am J Surg Pathol. 2017;41(7):941\u20139. https:\/\/doi.org\/10.1097\/PAS.0000000000000846.","journal-title":"Am J Surg Pathol"},{"key":"1648_CR7","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12957-025-03675-8","volume":"23","author":"C Li","year":"2025","unstructured":"Li C, Dong L, Zhu L, et al. Diagnostic utility of LEF1 and \u03b2-catenin in WNT pathway tumors with CTNNB1 mutation. World J Surg Onc. 2025;23:30. https:\/\/doi.org\/10.1186\/s12957-025-03675-8.","journal-title":"World J Surg Onc"},{"issue":"5","key":"1648_CR8","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1593\/tlo.12177","volume":"5","author":"KY Jang","year":"2012","unstructured":"Jang KY, Kim YN, Bae JS, et al. Expression of Cyclin D1 is associated with \u03b2-catenin expression and correlates with good prognosis in colorectal adenocarcinoma. Transl Oncol. 2012;5(5):370\u20138. https:\/\/doi.org\/10.1593\/tlo.12177.","journal-title":"Transl Oncol"},{"key":"1648_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-024-03770-4","author":"NAA Ebrahim","year":"2024","unstructured":"Ebrahim NAA, Abou-Bakr AA, Tawfik HN, et al. Decoding \u03b2-catenin expression patterns in ovarian serous carcinoma with clinicopathological implications: insights from National Cancer Institute. Clin Transl Oncol. 2024. https:\/\/doi.org\/10.1007\/s12094-024-03770-4.","journal-title":"Clin Transl Oncol"},{"key":"1648_CR10","doi-asserted-by":"publisher","unstructured":"Salwa N, Rym D, Raoudha D, Lamia C, Imen A, Maha D, Karima M. (2021). Solid pseudopapillary tumor of the pancreas: E-cadherin, \u03b2-catenin, CD99 new useful markers with characteristic expression (about two case reports). Pan Afr Med J 40;110. https:\/\/doi.org\/10.11604\/pamj.2021.40.110.2423","DOI":"10.11604\/pamj.2021.40.110.2423"},{"issue":"6","key":"1648_CR11","first-page":"853","volume":"30","author":"T Fujii","year":"2017","unstructured":"Fujii T, et al. LEF1 as a diagnostic marker for solid pseudopapillary tumors of the pancreas. Mod Pathol. 2017;30(6):853\u201360.","journal-title":"Mod Pathol"},{"key":"1648_CR12","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13000-022-01250-3","volume":"17","author":"D Wang","year":"2022","unstructured":"Wang D, Gong J, Zhang H, et al. Immunohistochemical staining of LEF-1 is a useful marker for distinguishing WNT-activated medulloblastomas. Diagn Pathol. 2022;17:69. https:\/\/doi.org\/10.1186\/s13000-022-01250-3.","journal-title":"Diagn Pathol"},{"key":"1648_CR13","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s13000-024-01577-z","volume":"19","author":"Y Yang","year":"2024","unstructured":"Yang Y, Song L, Yin Y, et al. Clinical significance of Cyclin D1 by complete quantification detection in mantle cell lymphoma: positive indicator in prognosis. Diagn Pathol. 2024;19:149. https:\/\/doi.org\/10.1186\/s13000-024-01577-z.","journal-title":"Diagn Pathol"},{"issue":"10","key":"1648_CR14","doi-asserted-by":"publisher","first-page":"5522","DOI":"10.1073\/pnas.96.10.5522","volume":"96","author":"M Shtutman","year":"1999","unstructured":"Shtutman M, Zhurinsky J, Simcha I, Albanese C, D\u2019Amico M, Pestell R, Ben-Ze\u2019ev A. The cyclin D1 gene is a target of the beta-catenin\/LEF-1 pathway. Proc Natl Acad Sci USA. 1999;96(10):5522\u20137. https:\/\/doi.org\/10.1073\/pnas.96.10.5522.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"1648_CR15","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.jamcollsurg.2005.02.011","volume":"200","author":"T Papavramidis","year":"2005","unstructured":"Papavramidis T, Papavramidis S. Solid pseudopapillary tumors of the pancreas: review of 718 patients reported in English literature. J Am Coll Surg. 2005;200(6):965\u201372.","journal-title":"J Am Coll Surg"},{"key":"1648_CR16","volume-title":"WHO classification of tumours of the digestive system","author":"FT Bosman","year":"2010","unstructured":"Bosman FT, Carneiro F, Hruban RH, et al. WHO classification of tumours of the digestive system. Geneva: World Health Organization; 2010."},{"issue":"3","key":"1648_CR17","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1097\/MPA.0000000000000061","volume":"43","author":"JK Law","year":"2014","unstructured":"Law JK, Ahmed A, Singh VK, et al. A systematic review of solid-pseudopapillary neoplasms: are these rare lesions? Pancreas. 2014;43(3):331\u20137.","journal-title":"Pancreas"},{"issue":"16","key":"1648_CR18","doi-asserted-by":"publisher","first-page":"6030","DOI":"10.1002\/cam4.3180","volume":"9","author":"J Wu","year":"2020","unstructured":"Wu J, Mao Y, Jiang Y, et al. Sex differences in solid pseudopapillary neoplasm of the pancreas: a population-based study. Cancer Med. 2020;9(16):6030\u201341.","journal-title":"Cancer Med"},{"issue":"4","key":"1648_CR19","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.pan.2017.12.012","volume":"18","author":"P Wang","year":"2018","unstructured":"Wang P, Wei J, Wu J, et al. Diagnosis and treatment of solid-pseudopapillary tumors of the pancreas: a single institution experience with 97 cases. Pancreatology. 2018;18(4):415\u20139.","journal-title":"Pancreatology"},{"issue":"4","key":"1648_CR20","doi-asserted-by":"publisher","first-page":"e233","DOI":"10.1097\/MPH.0000000000001049","volume":"40","author":"HJ Leraas","year":"2018","unstructured":"Leraas HJ, Kim J, Sun Z, et al. Solid pseudopapillary neoplasm of the pancreas in children and adults: a national study of 369 patients. J Pediatr Hematol Oncol. 2018;40(4):e233\u20136.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"2","key":"1648_CR21","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/PAS.0000000000000141","volume":"38","author":"JS Estrella","year":"2014","unstructured":"Estrella JS, Li L, Rashid A, et al. Solid pseudopapillary neoplasm of the pancreas: clinicopathologic and survival analyses of 64 cases from a single institution. Am J Surg Pathol. 2014;38(2):147\u201357.","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"1648_CR22","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1097\/00000478-200010000-00005","volume":"24","author":"K Notohara","year":"2000","unstructured":"Notohara K, Hamazaki S, Tsukayama C, Nakamoto S, Kawabata K, Mizobuchi K, Sakamoto K, Okada S. Solid-pseudopapillary tumor of the pancreas: immunohistochemical localization of neuroendocrine markers and CD10. Am J Surg Pathol. 2000;24(10):1361\u201371. https:\/\/doi.org\/10.1097\/00000478-200010000-00005.","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"1648_CR23","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s12672-024-00905-5","volume":"15","author":"X Lu","year":"2024","unstructured":"Lu X, Chen H, Zhang T. Solid pseudopapillary neoplasm (SPN) of the pancreas: current understanding on its malignant potential and management. Discov Oncol. 2024;15(1):77. https:\/\/doi.org\/10.1007\/s12672-024-00905-5. (Published 2024 Mar 18).","journal-title":"Discov Oncol."},{"issue":"3","key":"1648_CR24","doi-asserted-by":"publisher","first-page":"614","DOI":"10.4251\/wjgo.v16.i3.614","volume":"16","author":"Y-C Xu","year":"2024","unstructured":"Xu Y-C, Fu D-L, Yang F. Unraveling the enigma: A comprehensive review of solid pseudopapillary tumor of the pancreas. World J Gastrointestinal Oncol. 2024;16(3):614\u201329. https:\/\/doi.org\/10.4251\/wjgo.v16.i3.614.","journal-title":"World J Gastrointestinal Oncol"},{"issue":"9","key":"1648_CR25","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1038\/modpathol.3800902","volume":"20","author":"K Tiemann","year":"2007","unstructured":"Tiemann K, Heitling U, Kosmahl M, Kl\u00f6ppel G. Solid pseudopapillary neoplasms of the pancreas show an interruption of the Wnt-signaling pathway and express gene products of 11q. Modern Pathol. 2007;20(9):955\u201360. https:\/\/doi.org\/10.1038\/modpathol.3800902.","journal-title":"Modern Pathol"},{"issue":"8","key":"1648_CR26","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1002\/1878-0261.12490","volume":"13","author":"P Selenica","year":"2019","unstructured":"Selenica P, Raj N, Kumar R, et al. Solid pseudopapillary neoplasms of the pancreas are dependent on the Wnt pathway. Mol Oncol. 2019;13(8):1684\u201392. https:\/\/doi.org\/10.1002\/1878-0261.12490.","journal-title":"Mol Oncol"},{"issue":"10","key":"1648_CR27","doi-asserted-by":"publisher","first-page":"e169","DOI":"10.1038\/oncsis.2015.28","volume":"4","author":"SN Payne","year":"2015","unstructured":"Payne SN, Maher ME, Tran NH, et al. PIK3CA mutations can initiate pancreatic tumorigenesis and are targetable with PI3K inhibitors. Oncogenesis. 2015;4(10):e169. https:\/\/doi.org\/10.1038\/oncsis.2015.28. (Published 2015 Oct 5).","journal-title":"Oncogenesis."},{"key":"1648_CR28","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1007\/s00535-015-1037-4","volume":"50","author":"H Matthaei","year":"2015","unstructured":"Matthaei H, Semaan A, Hruban RH. The genetic classification of pancreatic neoplasia. J Gastroenterol. 2015;50:520\u201332. https:\/\/doi.org\/10.1007\/s00535-015-1037-4.","journal-title":"J Gastroenterol"},{"issue":"4","key":"1648_CR29","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/S0002-9440(10)62563-1","volume":"160","author":"SC Abraham","year":"2002","unstructured":"Abraham SC, Klimstra DS, Wilentz RE, et al. Solid-pseudopapillary tumors of the pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor beta-catenin mutations. Am J Pathol. 2002;160(4):1361\u20139.","journal-title":"Am J Pathol"},{"issue":"2","key":"1648_CR30","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1097\/SLA.0000000000000583","volume":"260","author":"CM Kang","year":"2014","unstructured":"Kang CM, Choi SH, Kim SC, et al. Predicting recurrence of pancreatic solid pseudopapillary tumors after surgical resection: a multicenter analysis in Korea. Ann Surg. 2014;260(2):348\u201355.","journal-title":"Ann Surg"},{"issue":"11","key":"1648_CR31","doi-asserted-by":"publisher","first-page":"e0143452","DOI":"10.1371\/journal.pone.0143452","volume":"10","author":"C Zhang","year":"2015","unstructured":"Zhang C, Liu F, Chang H, et al. Less aggressive surgical procedure for treatment of solid pseudopapillary tumor. PLoS ONE. 2015;10(11):e0143452.","journal-title":"PLoS ONE"},{"issue":"4","key":"1648_CR32","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1097\/01.pas.0000155159.28530.88","volume":"29","author":"LH Tang","year":"2005","unstructured":"Tang LH, Aydin H, Brennan MF, et al. Clinically aggressive solid pseudopapillary tumors of the pancreas. Am J Surg Pathol. 2005;29(4):512\u20139.","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"1648_CR33","doi-asserted-by":"publisher","first-page":"94","DOI":"10.5152\/dir.2016.16104","volume":"23","author":"G Anil","year":"2017","unstructured":"Anil G, Zhang J, Al Hamar NE, et al. Solid pseudopapillary neoplasm of the pancreas: CT imaging features and radiologic-pathologic correlation. Diagn Interv Radiol. 2017;23(2):94\u20139.","journal-title":"Diagn Interv Radiol"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-025-01648-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-025-01648-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-025-01648-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T10:38:39Z","timestamp":1746009519000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-025-01648-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,30]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1648"],"URL":"https:\/\/doi.org\/10.1186\/s13000-025-01648-9","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,30]]},"assertion":[{"value":"27 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained from the International Review Board of the National Cancer Institute, Cairo University, (Approval number PA2502 -\u2009501\u2013091 -\u2009196, IRB number IRB00004025). Informed consent was obtained from the patients. To maintain privacy and adhere to ethical guidelines, all identifying information has been removed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"57"}}